Woodland Breyer, Coorssen Jens R, Padula Matthew P
Proteomics, Lipidomics and Metabolomics Core Facility, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
Department of Biological Sciences, Faculty of Mathematics and Science, Brock University, St. Catharines, ON, Canada.
Front Cell Dev Biol. 2024 Dec 10;12:1504098. doi: 10.3389/fcell.2024.1504098. eCollection 2024.
The identification of effective, selective biomarkers and therapeutics is dependent on truly deep, comprehensive analysis of proteomes at the proteoform level.
Bovine serum albumin (BSA) isolated by two different protocols, cold ethanol fractionation and heat shock fractionation, was resolved and identified using Integrative Top-down Proteomics, the tight coupling of two-dimensional gel electrophoresis (2DE) with liquid chromatography and tandem mass spectrometry (LC-MS/MS).
Numerous proteoforms were identified in both "purified" samples, across a broad range of isoelectric points and molecular weights. The data highlight several concerns regarding proteome analyses using currently popular analytical approaches and what it means to (i) purify a "protein" if the isolate consists of a wide variety of proteoforms and/or co-purifying species; and (ii) use these preparations as analytical standards or therapeutics. Failure to widely recognize and accept proteome complexity has likely delayed the identification of effective biomarkers and new, more selective drug targets. iTDP is the most logical available analytical technique to effectively provide the necessary critical depth and breadth for complex proteome analyses. Routine analyses at the level of proteoforms will provide the much-needed data for the development and validation of selective biomarkers and drugs, including biologics.
有效、选择性生物标志物和治疗方法的鉴定依赖于在蛋白质异构体水平上对蛋白质组进行真正深入、全面的分析。
使用整合自上而下蛋白质组学(二维凝胶电泳(2DE)与液相色谱和串联质谱(LC-MS/MS)的紧密结合)对通过两种不同方案(冷乙醇分级分离和热休克分级分离)分离的牛血清白蛋白(BSA)进行解析和鉴定。
在两个“纯化”样品中均鉴定出大量蛋白质异构体,其等电点和分子量范围广泛。数据突出了使用当前流行分析方法进行蛋白质组分析的几个问题,以及如果分离物由多种蛋白质异构体和/或共纯化物种组成,那么(i)纯化“蛋白质”意味着什么;(ii)将这些制剂用作分析标准或治疗方法意味着什么。未能广泛认识和接受蛋白质组的复杂性可能延迟了有效生物标志物和新的、更具选择性的药物靶点的鉴定。整合自上而下蛋白质组学是目前最合理的分析技术,能够有效地为复杂蛋白质组分析提供必要的关键深度和广度。在蛋白质异构体水平上进行常规分析将为选择性生物标志物和药物(包括生物制品)的开发和验证提供急需的数据。